Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis

Assessment of linezolid efficacy and safety in MDR- and XDR-TB: an Indian perspective

(2010) Z. F. Udwadia et al.   EUROPEAN RESPIRATORY JOURNAL

Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06

(2010) H. A. Anger et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacokinetics and Whole‐Blood Bactericidal Activity againstMycobacterium tuberculosisof Single Doses of PNU‐100480 in Healthy Volunteers

(2010) Robert S. Wallis et al.   JOURNAL OF INFECTIOUS DISEASES

Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

(2010) Robert S Wallis et al.   LANCET

Addition of PNU-100480 to First-Line Drugs Shortens the Time Needed to Cure Murine Tuberculosis

(2009) Kathy N. Williams et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis

(2009) G. B. Migliori et al.   EUROPEAN RESPIRATORY JOURNAL

Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis

(2009) W.-J. Koh et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis

(2009) J.-E. Hugonnet et al.   SCIENCE

Strain specificity of antimycobacterial immunity in whole blood culture after cure of tuberculosis

(2009) Robert S. Wallis et al.   TUBERCULOSIS

Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model

(2008) K. N. Williams et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Case Series Report of a Linezolid-Containing Regimen for Extensively Drug-Resistant Tuberculosis*

(2008) Rany Condos et al.   CHEST

Post-antibiotic effects of linezolid and other agents against Mycobacterium tuberculosis

(2008) M. Hui et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis

(2008) Hae-Seong Nam et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS